Abstract
The purpose of this article is to report the methods, results, and conclusions of a pilot study developed to test a depression therapy component to reduce depressive symptoms in injection drug users. The pilot study was conducted to determine if the depression therapy component should be added as an adjunct to a social-network HIV risk-reduction intervention. The major conclusion from our pilot study was that depression therapy appears to be effective in reducing depressive symptoms in injection drug users and should be tested to improve treatment outcome of depressed drug users participating in HIV risk-reduction interventions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
